Vimarsana
Biggest News Aggregation in the World

Page 2 - Beyondspring Daily News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Beyondspring Daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Beyondspring Daily Today - Breaking & Trending Today

Head to Head Contrast: BeyondSpring (NASDAQ:BYSI) and Mateon Therapeutics (OTCMKTS:MATN) - Vimarsana News

Head to Head Contrast: BeyondSpring (NASDAQ:BYSI) and Mateon Therapeutics (OTCMKTS:MATN)

BeyondSpring (NASDAQ:BYSI – Get Rating) and Mateon Therapeutics (OTCMKTS:MATN – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, earnings, risk, profitability, institutional ownership, dividends and valuation. Earnings and Valuation This table compares BeyondSpring and Mateon Therapeutics’ […]

BeyondSpring (NASDAQ:BYSI) & Enlivex Therapeutics (NASDAQ:ENLV) Critical Review - Vimarsana News

BeyondSpring (NASDAQ:BYSI) & Enlivex Therapeutics (NASDAQ:ENLV) Critical Review

BeyondSpring (NASDAQ:BYSI – Get Rating) and Enlivex Therapeutics (NASDAQ:ENLV – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, dividends, risk, earnings, profitability and valuation. Risk & Volatility BeyondSpring has a beta of 0.09, indicating […]

Comparing BeyondSpring (NASDAQ:BYSI) and Enlivex Therapeutics (NASDAQ:ENLV) - Vimarsana News

Comparing BeyondSpring (NASDAQ:BYSI) and Enlivex Therapeutics (NASDAQ:ENLV)

BeyondSpring (NASDAQ:BYSI – Get Rating) and Enlivex Therapeutics (NASDAQ:ENLV – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, analyst recommendations, dividends, earnings and profitability. Profitability This table compares BeyondSpring and Enlivex Therapeutics’ net margins, […]

Source: wkrb13.com
Robert W. Baird Lowers BeyondSpring (NASDAQ:BYSI) Price Target to $1.25 - Vimarsana News

Robert W. Baird Lowers BeyondSpring (NASDAQ:BYSI) Price Target to $1.25

BeyondSpring (NASDAQ:BYSI – Get Rating) had its target price cut by analysts at Robert W. Baird from $4.00 to $1.25 in a research report issued to clients and investors on Tuesday, The Fly reports. Robert W. Baird’s price objective suggests a potential upside of 39.98% from the stock’s previous close. BeyondSpring Stock Down 5.6 % […]